期刊文献+

Impact of RT-PCR monitoring on the long-term survival in acute promyelocytic leukemia

Impact of RT-PCR monitoring on the long-term survival in acute promyelocytic leukemia
原文传递
导出
摘要 Obejctive To evaluate the impact of kinetics of molecular remission via retro transcriptase polymerase chain reaction (RT PCR) assay on the long term survival in patients with acute promyelocytic leukemia (APL) Methods Seventy patients with newly diagnosed APL in remission were involved in this study Monitoring of minimal residual disease (MRD) was performed regularly by RT PCR assay for PML RARα during consolidation Results A 5 year relapse free survival (RFS) and overall survival (OS) were estimated as 46 8%±8 4% and 69 9%±9 4% for the whole group Fifty two (74 3%) patients got negative RT PCR result at least once Serial monitoring of RT PCR was available in 38 cases and 24 (63 2%) patients presented with persistent negative PCR results The achievement and continuous negative RT PCR result was significantly related to the RFS Conclusions Achievement of negative RT PCR in remission is associated with favorable RFS and OS Continuous negative RT PCR results are associated with long term relapse free survival and may be considered as potentially curative RT PCR assay for detection of MRD should be performed regularly during post remission period as an important prognostic factor Obejctive To evaluate the impact of kinetics of molecular remission via retro transcriptase polymerase chain reaction (RT PCR) assay on the long term survival in patients with acute promyelocytic leukemia (APL) Methods Seventy patients with newly diagnosed APL in remission were involved in this study Monitoring of minimal residual disease (MRD) was performed regularly by RT PCR assay for PML RARα during consolidation Results A 5 year relapse free survival (RFS) and overall survival (OS) were estimated as 46 8%±8 4% and 69 9%±9 4% for the whole group Fifty two (74 3%) patients got negative RT PCR result at least once Serial monitoring of RT PCR was available in 38 cases and 24 (63 2%) patients presented with persistent negative PCR results The achievement and continuous negative RT PCR result was significantly related to the RFS Conclusions Achievement of negative RT PCR in remission is associated with favorable RFS and OS Continuous negative RT PCR results are associated with long term relapse free survival and may be considered as potentially curative RT PCR assay for detection of MRD should be performed regularly during post remission period as an important prognostic factor
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2000年第10期35-38,共4页 中华医学杂志(英文版)
关键词 acute promyelocytic leukemia RT PCR minimal residual disease acute promyelocytic leukemia · RT PCR · minimal residual disease
  • 相关文献

参考文献8

  • 1Asou N,Adachi K,Tamura J,et al.Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Journal of Clinical Oncology . 1998
  • 2Lo Coco F,Nervi C,Avvisati G,et al.Acute promyelocytic leukemia: a curable disease. Leukemia . 1998
  • 3Huang W,Sun GL,Li XS,et al.Acute promyelocytic leukemia: clinical relevance of two major PML/RARαisoform and detection of minimal residual disease by retro-transcriptase polymerase chain reaction to predict relapse. Blood . 1993
  • 4Biondi A,Rambaldi A,Pandolfi PP,et al.Molecular monitoring of the MYL/RARαfusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood . 1992
  • 5Lo Coco F,Diverio D,Pandolfi PP,et al.Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. The Lancet . 1998
  • 6Diverio D,Rossi V,Avvisati G,et al.Early detection of relapse by prospective retro-transcriptase polymerase chain reaction of PML/RARαfusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter"AIDA"trial.GIMEMAAIEOP multicenter"AIDA"trial. Blood . 1998
  • 7Burnett AK,Grimwade D,Solomon E,et al.Presenting WBC and kinetics of molecular remission predict prognosis in acute promyelocyte leukemia treated with ATRA: results of the randomized MRC trial. Blood . 1999
  • 8Mandelli F,Daniela D,Avvisati G,et al.Molecular remission in PML-RARαpositive acute promyelocytic leukemia by combined alltrans retinoic acid and idarubicin (AIDA) therapy. Blood . 1997

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部